Patents by Inventor Jonas Dyhrfjeld-Johnsen

Jonas Dyhrfjeld-Johnsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PREVENTING COCHLEAR DISEASE, DISORDER OR CONDITION USING (+)-AZASETRON
    Publication number: 20230226071
    Abstract: Disclosed is a method for treating ear disorders, including the administration of (+)-azasetron, or a pharmaceutically acceptable salt and/or solvate thereof.
    Type: Application
    Filed: March 13, 2023
    Publication date: July 20, 2023
    Inventor: Jonas DYHRFJELD-JOHNSEN
  • (+)-azasetron for use in the treatment of ear disorders
    Patent number: 11612605
    Abstract: Disclosed is a method for treating ear disorders, including the administration of (+)-azasetron, or a pharmaceutically acceptable salt and/or solvate thereof.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: March 28, 2023
    Assignee: SENSORION
    Inventor: Jonas Dyhrfjeld-Johnsen
  • CALCINEURIN INHIBITORS OF THE SETRON FAMILY FOR THE TREATMENT OF HEARING LOSS
    Publication number: 20220387438
    Abstract: Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Inventor: Jonas DYHRFJELD-JOHNSEN
  • Calcineurin inhibitors of the setron family for the treatment of hearing loss
    Patent number: 11433077
    Abstract: Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: September 6, 2022
    Assignee: SENSORION
    Inventor: Jonas Dyhrfjeld-Johnsen
  • TREATMENT AND/OR PREVENTION OF LESIONS IN THE CENTRAL AUDITORY NERVOUS SYSTEM
    Publication number: 20220265668
    Abstract: The therapeutic use of azasetron or an analogue thereof for treating and/or preventing a lesion in the central auditory nervous system (CANS) in an individual. The treatment of lesions in the CANS with azasetron also prevents, inhibits, and/or reduces the loss of the central auditory neuron cells in the brainstem.
    Type: Application
    Filed: July 24, 2020
    Publication date: August 25, 2022
    Applicant: SENSORION
    Inventor: Jonas DYHRFJELD-JOHNSEN
  • (+)-AZASETRON FOR USE IN THE TREATMENT OF EAR DISORDERS
    Publication number: 20190083503
    Abstract: Disclosed is a method for treating ear disorders, including the administration of (+)-azasetron, or a pharmaceutically acceptable salt and/or solvate thereof.
    Type: Application
    Filed: April 14, 2017
    Publication date: March 21, 2019
    Inventor: Jonas DYHRFJELD-JOHNSEN
  • Calcineurin inhibitors for use in the treatment of lesional vestibular disorders
    Patent number: 10188695
    Abstract: The present invention relates to a calcineurin inhibitor for use in the treatment of a lesional vestibular disorder.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: January 29, 2019
    Assignees: Sensorion, INSERM
    Inventor: Jonas Dyhrfjeld-Johnsen
  • CALCINEURIN INHIBITORS OF THE SETRON FAMILY FOR THE TREATMENT OF HEARING LOSS
    Publication number: 20180207167
    Abstract: Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof.
    Type: Application
    Filed: May 18, 2016
    Publication date: July 26, 2018
    Applicant: SENSORION
    Inventor: Jonas DYHRFJELD-JOHNSEN
  • CALCINEURIN INHIBITORS FOR USE IN THE TREATMENT OF LESIONAL VESTIBULAR DISORDERS
    Publication number: 20150057233
    Abstract: The present invention relates to a calcineurin inhibitor for use in the treatment of a lesional vestibular disorder.
    Type: Application
    Filed: February 22, 2013
    Publication date: February 26, 2015
    Inventor: Jonas Dyhrfjeld-Johnsen